Navigation Links
Quark Pharmaceuticals and Major Pharmaceutical Company Enter into Licensing Option Agreement for the p53 Suppressor Drug QPI-1002, the First siRNA Administered Systemically in Human
Date:8/18/2010

eserve RNAi activity while ameliorating potential off-target and immunostimulatory effects of siRNAs.

Quark is also committed to leveraging a broad research pipeline of siRNA drug candidates and novel siRNA structures to develop additional RNAi drug candidates.

Quark is headquartered in Fremont, California and operates research and development facilities in Boulder, Colorado and Ness-Ziona, Israel. Additional information is available at www.quarkpharma.com.Quark Pharmaceuticals, Inc.The Ruth Group (investors / media)Juliana Friedman

Sara Pellegrino / Jason Rando+972 89 30 5111

(646) 536-7002 / 7025jfriedman@quarkpharma.com

spellegrino@theruthgroup.comjrando@theruthgroup.com
'/>"/>

SOURCE Quark Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
2. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
3. Quark Pharmaceuticals Files Patent Application Covering Novel Chemical Modifications to its RNAi Molecules
4. Quark Pharmaceuticals Appoints New Chief Medical Officer
5. Quark Pharmaceuticals Signs Collaboration Agreement With University of Michigan for Development of Proprietary SiRNA Compounds for Noise-Induced Hearing Loss
6. Quark Pharmaceuticals, Inc. Announces First Systemic siRNA Dosing in Humans
7. Quark Pharmaceuticals Announces First Patient Dosing by Pfizer in Phase II Trial of RNAi Therapy in Diabetic Macular Edema
8. Silence Therapeutics to Receive $1.9m Milestone Payment as Pfizer and Quark Commence Phase II Trial
9. Quark Pharmaceuticals Announces First RNAi Drug Candidate Having a Novel, Proprietary Structure Covered by Quark Intellectual Property
10. Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy
11. Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... WASHINGTON , Jan. 15, 2014 AARP Foundation today ... support older adults suffering from the severe cold weather that ... are committed to helping those in need; so to support ... dollar-for-dollar contributions up to $250,000, which could mean up to ...
(Date:1/15/2014)... Jan. 15, 2014 Massachusetts General Hospital (MGH), ... AMGN ) announced today that they have launched ... new therapeutic targets and develop novel therapies for ... affects millions worldwide. The MGH-Broad-Amgen collaboration brings together ...
(Date:1/15/2014)... BreedIT Corp (OTC: BRDT), through its Israeli ... sophisticated agro-breeding solutions for plant breeders and researchers, today ... of directors appointed chemistry and pharmaceutical industry expert Dr. ... the board. From 1975 to 2012, Dr. ...
Breaking Medicine Technology:AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3
(Date:7/11/2014)... The International Concussion Organization is hosting ... Buy Theater in Times Square, New York on ... concussion epidemic that is plaguing athletes in nearly ... , The Symposium gathers more than a dozen ... athletes and legal scholars for engaging and uniquely ...
(Date:7/11/2014)... New Mexico (PRWEB) July 11, 2014 ... stress disorder are just some of the increasing numbers ... them to lead more independent and productive lives. ... the workplace? Or is an assistance dog an impediment ... Assistance Dog Week , August 3 - 9, 2014, ...
(Date:7/11/2014)... 2014 Shu Cosmetic Surgery announces ... each qualifying patient undergoing a laser vaginal ... laser vaginal rejuvenation, an advanced type of vaginal ... procedure decreases the internal and external diameters of ... strength, and control, resulting in enhanced sexual gratification ...
(Date:7/10/2014)... The Capital Institute for Neurosciences at ... procedure in a clinical trial that delivers chemotherapy to ... , During the procedure, done at Capital Health Medical ... threaded a tiny catheter through the patient’s femoral artery ... and into the brain. Once the catheter reached the ...
(Date:7/10/2014)... 10, 2014 Thousands of researchers ... Copenhagen this July 13-17 to reveal the latest ... closer to breakthroughs in dementia science. The Alzheimer’s ... conference of its kind. , As part of ... a catalyst for generating new knowledge about dementia ...
Breaking Medicine News(10 mins):Health News:The International Concussion Organization 501(c)(3) hosts its 1st Annual Concussion Symposium at the Best Buy Theater in Time Square, NYC, July 17th, 2014. 2Health News:Will Your Next Employee or Co-Worker Be a Dog? 2Health News:Will Your Next Employee or Co-Worker Be a Dog? 3Health News:Will Your Next Employee or Co-Worker Be a Dog? 4Health News:Shu Cosmetic Surgery of Twin Cities Now Offers Complimentary Perineoplasty in Laser Vaginal Rejuvenation 2Health News:Shu Cosmetic Surgery of Twin Cities Now Offers Complimentary Perineoplasty in Laser Vaginal Rejuvenation 3Health News:New Trial Delivers Chemotherapy to Brain Tumor Through Artery in Leg 2Health News:New Trial Delivers Chemotherapy to Brain Tumor Through Artery in Leg 3
... and Philadelphia, US June 17, 2008 Shire ... company, today announced the publication of data from a ... ulcerative colitis (UC) drug Lialda™ (mesalamine). The primary endpoints ... tolerability of Lialda in mild-to-moderate UC patients over 12 ...
... the 54th Summer Fancy Food Show in New York City from June ... ... WORLDFOODS provides the perfect,product for those with food allergies, are lactose ... out on,great taste. WORLDFOODS offers an exciting variety of 59 types of ...
... Patient Advocate Foundation in Supporting,Progressive, Financially Sound and ... Support by Wearing Blue and Yellow Ribbons on,June ... the,need for all patients in Tennessee to have ... strikes, Governor Phil Bredesen, for the,second consecutive year, ...
... 17 Kimberly-Clark Professional is,donating thousands of health ... residents clean up from the extensive damage caused ... was hit very hard by these storms and ... of,Kimberly-Clark Professional, North America. "At Kimberly-Clark,Professional, our mission ...
... Provide Perfect Medium for Showing Support and, Generating Awareness - ... ... SAN MATEO, Calif., June 17 CafePress, the recognized,leader in ... launched Stand Up To Cancer initiative, to raise money for,research geared ...
... July 18-20, WASHINGTON, June 17 A ... plans and health networks wrestling with,market demands for ... services., (Logo: http://www.newscom.com/cgi-bin/prnh/20030501/URACLOGO ), ... Institute, June 18-20,in San Francisco. URAC is an ...
Cached Medicine News:Health News:Long-term safety data on Lialda published in leading GI journal 2Health News:Long-term safety data on Lialda published in leading GI journal 3Health News:WORLDFOODS Provides All Natural Authentic Asian Sauces That Cater to Vegetarians, Celiacs and Those With Food Allergies 2Health News:Governor Bredesen Declares Tennessee Patient Advocacy Day to Promote Healthcare Accessibility for All 2Health News:Governor Bredesen Declares Tennessee Patient Advocacy Day to Promote Healthcare Accessibility for All 3Health News:CafePress Supports Stand Up To Cancer With Online Store to Help Raise Awareness and Funds for Research 2Health News:New URAC Issue Brief Answers Questions About Delegated Credentialing, Transparency in Physician Tiering Programs 2Health News:New URAC Issue Brief Answers Questions About Delegated Credentialing, Transparency in Physician Tiering Programs 3
... important missions, require dependable transport ... your destination. The VIKING Guiding ... So you can set your ... not have to think about ...
Designed for young and disabled children but equally suitable for older children and adults., ,Optional 6/60 to 6/24 booklet available for patients who fail standard screening test and require fu...
... RX ACCULINK Carotid Stent System is designed to ... who have carotid atherosclerosis and are at high ... wire compatible RX ACCULINK Carotid Stent System is ... stent sizes. The RX ACCULINK utilizes rapid exchange ...
Tests for protan and deutan defects. Patients must identify numbers or patterns formed in a matrix of small colored dots varying in color and intensity. Two editions available: 38 plate for detailed ...
Medicine Products: